Inhaled PPP001 Versus Buccal Tablets for the Management of Breakthrough Pain in Cancer Patients: an Open Label, Crossover, Comparison Study Followed by a Randomized, Double-blind, Placebo-controlled Pilot Trial
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2018
Price : $35 *
At a glance
- Drugs Marijuana (Primary) ; Fentanyl
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Tetra Bio Pharma
- 26 Nov 2018 Status changed from not yet recruiting to recruiting, according to a Tetra Bio Pharma media release.
- 12 Nov 2018 Planned End Date changed from 31 Mar 2019 to 30 Jun 2019.
- 12 Nov 2018 Planned primary completion date changed from 31 Mar 2019 to 30 Jun 2019.